PMID: 9418252Jan 7, 1998Paper

Inhibition of metallo-beta-lactamases by a series of thiol ester derivatives of mercaptophenylacetic acid

FEMS Microbiology Letters
D J PayneR Reid

Abstract

A series of mercaptophenylacetic acid thiol esters bearing a phenyl substituent adjacent to the carboxylic acid function has been shown to be inhibitors of metallo-beta-lactamases. The inhibition of the Bacteroides fragilis CfiA and Bacillus cereus II metallo-beta-lactamases was Zn2- dependent, greater inhibition being observed at 1 microM ZnSO4 than at 100 microM ZnSO4. Despite this Zn2+ dependency, isothermal titration calorimetry studies illustrated that representative compounds had no detectable affinity for Zn2+ (K > 1 mM). This indicates that their mode of inhibition was not by chelation of the active site Zn2+. Greatest potency was observed against the Stenotrophomonas maltophilia L1 metallo-beta-lactamase with I50 values of between < 1.95 microM and 6 microM and SB-217843 exhibited a similar level of inhibition of this enzyme at 1 and 100 microM Zn2+ (I50 values 5 and 6 microM, respectively). Inhibition of B. cereus II metallo-beta-lactamase by SB-218018 and SB-217782 was competitive with Ki values of 185 microM and 1500 microM, respectively. Therefore, these compounds are specific inhibitors of metallo-beta-lactamases and provide further probes of the active sites of these enzymes.

References

Apr 1, 1993·The Biochemical Journal·A FeliciJ M Frère
Jan 1, 1997·Antimicrobial Agents and Chemotherapy·D J PayneJ Marchand-Brynaert
Feb 1, 1997·Antimicrobial Agents and Chemotherapy·B A Rasmussen, K Bush

❮ Previous
Next ❯

Citations

Jan 7, 1998·Protein Science : a Publication of the Protein Society·N O ConchaO Herzberg
Nov 30, 2000·Current Infectious Disease Reports·L B Rice, R A Bonomo
Feb 26, 2004·Bioorganic & Medicinal Chemistry Letters·John D BuynakTimothy R Walsh
Mar 18, 2004·Bioorganic & Medicinal Chemistry Letters·Wing Y TsangMichael I Page
Apr 6, 2002·FEMS Microbiology Letters·Brian J DennyPatrick W J West
Sep 25, 1999·Bioorganic & Medicinal Chemistry Letters·M L GreenleeJ H Epstein-Toney
Oct 6, 1999·Bioorganic & Medicinal Chemistry Letters·J H ToneyD E Vanderwall
Mar 16, 2001·Bioorganic & Medicinal Chemistry·S BounagaM I Page
Jan 16, 2002·Drug Discovery Today·Jac C H M Wijkmans, R Paul Beckett
Aug 1, 1997·Current Opinion in Chemical Biology·K Bush
Oct 6, 1999·Current Opinion in Chemical Biology·Z WangS J Benkovic
Feb 4, 2010·Journal of Medicinal Chemistry·Peter OelschlaegerJeffrey H Toney
Mar 13, 2010·The Journal of Antibiotics·Deborah M RollMay D Lee
Jul 4, 2001·European Journal of Biochemistry·A ZervosenM Galleni
Oct 19, 2000·Antimicrobial Agents and Chemotherapy·N FranceschiniG M Rossolini
Jul 18, 2002·Antimicrobial Agents and Chemotherapy·Stefan SiemannGary I Dmitrienko
Feb 26, 2004·Antimicrobial Agents and Chemotherapy·Pilar Gutiérrez NavarroM Carmen Cabeza González
Apr 16, 2005·Clinical Microbiology Reviews·Timothy R WalshPatrice Nordmann
Apr 4, 2003·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Xiang-Hua YinTeruhiko Tamaya
Jul 19, 2013·Future Medicinal Chemistry·Dustin T King, Natalie C J Strynadka
Jan 13, 2006·Angewandte Chemie·James Spencer, Timothy R Walsh
Oct 11, 2014·Chembiochem : a European Journal of Chemical Biology·Pei W ThomasWalter Fast
Nov 4, 2000·Expert Opinion on Investigational Drugs·D J PayneJ H Bateson
Jul 23, 1999·Archives of Biochemistry and Biophysics·K W Yang, M W Crowder
May 2, 2013·Biochimica Et Biophysica Acta·Walter Fast, Larry D Sutton
Jul 14, 2004·Protein Expression and Purification·Patrick A CrawfordMichael W Crowder
Oct 24, 2003·The Journal of Biological Chemistry·James D GarrityMichael W Crowder
Apr 9, 2001·The Journal of Pharmacy and Pharmacology·K Poole
Apr 10, 2003·The Journal of Biological Chemistry·Isabel García-SaezOtto Dideberg
Sep 21, 2001·The Journal of Biological Chemistry·C MollardG C Roberts
Jun 8, 2001·The Journal of Biological Chemistry·J H ToneyY D Gao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.